Announcements
- KALA BIO to Present at Jefferies Global Healthcare Conference
- KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
- KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
- KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
- KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
- KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- KALA BIO to Participate in Upcoming Investor Conferences in August
More ▼
Key statistics
On Friday, KALA BIO Inc (27F0:FRA) closed at 5.87, 23.68% above the 52 week low of 4.74 set on Nov 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.86 |
---|---|
High | 5.87 |
Low | 5.86 |
Bid | 6.20 |
Offer | 6.45 |
Previous close | 5.64 |
Average volume | 1.40 |
---|---|
Shares outstanding | 2.82m |
Free float | 2.49m |
P/E (TTM) | -- |
Market cap | 18.93m USD |
EPS (TTM) | -15.15 USD |
Data delayed at least 15 minutes, as of May 31 2024 14:43 BST.
More ▼